Multicellular living organisms and unmodified parts thereof and – Nonhuman animal
Patent
1995-08-31
1999-10-12
Chambers, Jasemine C.
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
435 72, 4353201, 4351723, 424 91, 424 9321, C12N 1563, C12N 510, C12N 1509
Patent
active
059657871
ABSTRACT:
Disclosed are transgenic mice carrying a human HLA-DQ sgene. The transgenic mice are deficient in mouse H-2 class II molecules. Such mice provide animal model systems to identify peptides useful for preventing or treating rheumatoid arthritis. Also disclosed are methods and materials for treating rheumatoid arthritis, including administration of peptides having specific binding affinity for HLA-DQ molecules expressed in a rheumatoid arthritis patient.
REFERENCES:
Fugger et al., Proc. Natl. Acad. Sci. USA 91:6151-6155, 1994.
Salvat et al., J. of Immunology 153:5321-5329, 1994.
Bodmer et al., Tissue Antigens, 39:161-175, 1992.
Bodmer et al., Tissue Antigens, 44:1-18, 1994.
Chen et al., Nature, 376:177-180, 1995.
Gonzalez-Gay et al., J. Exp. Med., 180:1559-1564, 1994.
Gonzalez-Gay et al., Immunogenetics, 42:35-40, 1995.
E. Harris, Ann. Intern. Med., 123:232-233, 1995.
Moder et al., Regional Immunology, 4:305-313, 1992.
Ikada et al., Proc. Natl. Acad. Sci. USA, 82:3410-3414, 1985.
David et al. "Role of HLA-DQ and HLA-DR transgenes in experimental arthritis implications in RA," Experimental Biology 95, Part II, Atlanta Georgia, FASEB J. vol. 9(4), abstract 5953, Apr. 9, 1995.
Zanelli et al. "DR-beta peptide reactivity of HLA-DQB10302 transgenic mice and implication for the Shared epitope hypothesis in rheumatoid arthritis," 9th International Congress of Immunology, S.F. CA, abstract 998, Jul. 23, 1995.
Nabozny et al. "Induction of Collagen induced arthritis (CIA) in HLA-DQ8 transgenic mice: Possible implication for HLA-DQ mediated susceptibility in human rheumatoid arthritis," 9th International Congress of Immunology, S.F. CA, abstract 999, Jul. 23, 1995.
Griffiths et al. "Identification of the dominant antibody reactivities to the renatured cyanogen bromide (CB) fragments of type II collagen in HLA-DQw8 transgenic mice with collagen-induced arthritis," 9th International Congress of Immunology, S.F. CA, ab, Jul. 23, 1995.
Kappel et al. "Regulating gene expression in transgenic animals," Current Opinion in Biotechnology, vol. 3: 548-553, 1992.
David Chella S.
Luthra Harvinder S.
Zanelli Eric
Chambers Jasemine C.
Hauda Karen M.
Mayo Foundation for Medical Education and Research
LandOfFree
HLA-DRBI peptides with specific binding affinity for HLA-DQ mole does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HLA-DRBI peptides with specific binding affinity for HLA-DQ mole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HLA-DRBI peptides with specific binding affinity for HLA-DQ mole will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-654476